Characterisation of [125I]-apamin binding sites in rat brain membranes and HEK293 cells transfected with SK channel subtypes
- 1 September 2001
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 41 (3) , 341-350
- https://doi.org/10.1016/s0028-3908(01)00067-3
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Block of rat brain recombinant SK channels by tricyclic antidepressants and related compoundsEuropean Journal of Pharmacology, 2000
- Bis-Quinolinium Cyclophanes: 6,10-Diaza-3(1,3),8(1,4)-dibenzena-1,5(1,4)- diquinolinacyclodecaphane (UCL 1684), the First Nanomolar, Non-Peptidic Blocker of the Apamin-Sensitive Ca2+-Activated K+ ChannelJournal of Medicinal Chemistry, 1998
- Isolation of a novel potassium channel gene hSKCa3 containing a polymorphic CAG repeat: a candidate for schizophrenia and bipolar disorder?Molecular Psychiatry, 1998
- Detection of adenosine receptor antagonists in rat brain using a modified radioreceptor assayJournal of Neuroscience Methods, 1997
- Discrimination between subtypes of apamin‐sensitive Ca2+‐ activated K+ channels by gallamine and a novel bis‐quaternary quinolinium cyclophane, UCL 1530British Journal of Pharmacology, 1996
- On the Concept of a Bivalent Pharmacophore for SKCa Channel Blockers: Synthesis, Pharmacological Testing, and Radioligand Binding Studies on Mono‐, Bis‐, and Tris‐quinolinium CompoundsArchiv der Pharmazie, 1996
- Synthesis and Quantitative Structure-Activity Relationship of Dequalinium Analogs as K+ Channel Blockers: Investigations on the Role of the Substituent at Position 4 of the Quinoline RingJournal of Medicinal Chemistry, 1995
- Neuromuscular blocking agents inhibit receptor‐mediated increases in the potassium permeability of intestinal smooth muscleBritish Journal of Pharmacology, 1985
- Effects of apamin, quinine and neuromuscular blockers on calcium‐activated potassium channels in guinea‐pig hepatocytes.The Journal of Physiology, 1985
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973